Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |